Literature DB >> 24389730

YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.

David Fu1, Xiangmin Lv, Guohua Hua, Chunbo He, Jixin Dong, Subodh M Lele, David Wan-Cheng Li, Qiongli Zhai, John S Davis, Cheng Wang.   

Abstract

The Hippo signaling pathway has been implicated as a conserved regulator of organ size in both Drosophila and mammals. Yes-associated protein (YAP), the central component of the Hippo signaling cascade, functions as an oncogene in several malignancies. Ovarian granulosa cell tumors (GCT) are characterized by enlargement of the ovary, excess production of estrogen, a high frequency of recurrence, and the potential for malignancy and metastasis. Whether the Hippo pathway plays a role in the pathogenesis of GCT is unknown. This study was conducted to examine the expression of YAP in human adult GCTs and to determine the role of YAP in the proliferation and steroidogenesis of GCT cells. Compared with age-matched normal human ovaries, GCT tissues exhibited higher levels of YAP expression. YAP protein was predominantly expressed in the nucleus of tumor cells, whereas the non-tumor ovarian stromal cells expressed very low levels of YAP. YAP was also expressed in cultured primary human granulosa cells and in KGN and COV434 GCT cell lines. siRNA-mediated knockdown of YAP in KGN cells resulted in a significant reduction in cell proliferation (P<0.001). Conversely, overexpression of wild type YAP or a constitutively active YAP (YAP1) mutant resulted in a significant increase in KGN cell proliferation and migration. Moreover, YAP knockdown reduced FSH-induced aromatase (CYP19A1) protein expression and estrogen production in KGN cells. These results demonstrate that YAP plays an important role in the regulation of GCT cell proliferation, migration, and steroidogenesis. Targeting the Hippo/YAP pathway may provide a novel therapeutic approach for GCT.

Entities:  

Keywords:  Hippo/YAP pathway; cell proliferation; granulosa cell tumor; migration; steroidogenesis

Mesh:

Substances:

Year:  2014        PMID: 24389730      PMCID: PMC4222524          DOI: 10.1530/ERC-13-0339

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  64 in total

Review 1.  Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature.

Authors:  Katherine D Crew; Michael H Cohen; Daniel H Smith; Amy D Tiersten; Nikki M Feirt; Dawn L Hershman
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

2.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.

Authors:  Antoine M Snijders; Brian L Schmidt; Jane Fridlyand; Nusi Dekker; Daniel Pinkel; Richard C K Jordan; Donna G Albertson
Journal:  Oncogene       Date:  2005-06-16       Impact factor: 9.867

3.  The putative G-protein coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPER-independent manner.

Authors:  Cheng Wang; Xiangmin Lv; Chao Jiang; John S Davis
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

4.  Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth.

Authors:  M K Skinner; J Keski-Oja; K G Osteen; H L Moses
Journal:  Endocrinology       Date:  1987-08       Impact factor: 4.736

5.  The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

Authors:  Sabrina Strano; Olimpia Monti; Natalia Pediconi; Alessia Baccarini; Giulia Fontemaggi; Eleonora Lapi; Fiamma Mantovani; Alexander Damalas; Gennaro Citro; Ada Sacchi; Giannino Del Sal; Massimo Levrero; Giovanni Blandino
Journal:  Mol Cell       Date:  2005-05-13       Impact factor: 17.970

6.  Promising effect of aromatase inhibitors on recurrent granulosa cell tumors.

Authors:  Jacob Korach; Tamar Perri; Mario Beiner; Tima Davidzon; Eddie Fridman; Gilad Ben-Baruch
Journal:  Int J Gynecol Cancer       Date:  2009-07       Impact factor: 3.437

7.  Expression of G protein-coupled receptor 30 in the hamster ovary: differential regulation by gonadotropins and steroid hormones.

Authors:  Cheng Wang; Eric R Prossnitz; Shyamal K Roy
Journal:  Endocrinology       Date:  2007-07-19       Impact factor: 4.736

8.  Estrogens augment the stimulation of ovarian aromatase activity by follicle-stimulating hormone in cultured rat granulosa cells.

Authors:  E Y Adashi; A J Hsueh
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

9.  YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.

Authors:  J-M Huang; I Nagatomo; E Suzuki; T Mizuno; T Kumagai; A Berezov; H Zhang; B Karlan; M I Greene; Q Wang
Journal:  Oncogene       Date:  2012-06-11       Impact factor: 9.867

10.  Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways.

Authors:  Cheng Wang; Xiangmin Lv; Chao Jiang; Crystal M Cordes; Lan Fu; Subodh M Lele; John S Davis
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more
  33 in total

1.  In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.

Authors:  Samantha Guillemette; Charlène Rico; Philippe Godin; Derek Boerboom; Marilène Paquet
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-08-18       Impact factor: 2.673

2.  P2Y2 Nucleotide Receptor Prompts Human Cardiac Progenitor Cell Activation by Modulating Hippo Signaling.

Authors:  Farid G Khalafalla; Steven Greene; Hashim Khan; Kelli Ilves; Megan M Monsanto; Roberto Alvarez; Monica Chavarria; Jonathan Nguyen; Benjamin Norman; Walter P Dembitsky; Mark A Sussman
Journal:  Circ Res       Date:  2017-09-18       Impact factor: 17.367

3.  A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.

Authors:  Katherine K Slemmons; Lisa E S Crose; Stefan Riedel; Manuela Sushnitha; Brian Belyea; Corinne M Linardic
Journal:  Mol Cancer Res       Date:  2017-09-18       Impact factor: 5.852

4.  Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling.

Authors:  Subramanyam Dasari; Angela Lincy Prem Antony Samy; Andre Kajdacsy-Balla; Maarten C Bosland; Gnanasekar Munirathinam
Journal:  Food Chem Toxicol       Date:  2018-02-09       Impact factor: 6.023

5.  YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.

Authors:  Chunbo He; Xiangmin Lv; Cong Huang; Guohua Hua; Bowen Ma; Xingcheng Chen; Peter C Angeletti; Jixin Dong; Jin Zhou; Zhengfeng Wang; Bo R Rueda; John S Davis; Cheng Wang
Journal:  EMBO Rep       Date:  2019-02-12       Impact factor: 8.807

Review 6.  Hippo signaling in the ovary and polycystic ovarian syndrome.

Authors:  Kristi Maas; Sheyla Mirabal; Alan Penzias; Paul M Sweetnam; Kevin C Eggan; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2018-08-17       Impact factor: 3.412

7.  G-1 Inhibits Breast Cancer Cell Growth via Targeting Colchicine-Binding Site of Tubulin to Interfere with Microtubule Assembly.

Authors:  Xiangmin Lv; Chunbo He; Cong Huang; Guohua Hua; Zhengfeng Wang; Steven W Remmenga; Kerry J Rodabough; Adam R Karpf; Jixin Dong; John S Davis; Cheng Wang
Journal:  Mol Cancer Ther       Date:  2017-03-03       Impact factor: 6.261

8.  Hypoglycosylated hFSH Has Greater Bioactivity Than Fully Glycosylated Recombinant hFSH in Human Granulosa Cells.

Authors:  Chao Jiang; Xiaoying Hou; Cheng Wang; Jeffrey V May; Viktor Y Butnev; George R Bousfield; John S Davis
Journal:  J Clin Endocrinol Metab       Date:  2015-04-27       Impact factor: 5.958

9.  Activated Hippo/Yes-Associated Protein Pathway Promotes Cell Proliferation and Anti-apoptosis in Endometrial Stromal Cells of Endometriosis.

Authors:  Yong Song; Jing Fu; Min Zhou; Li Xiao; Xue Feng; Hengxi Chen; Wei Huang
Journal:  J Clin Endocrinol Metab       Date:  2016-03-15       Impact factor: 5.958

Review 10.  The HIPPO pathway in gynecological malignancies.

Authors:  Dongying Wang; Jiaxing He; Junxue Dong; Thomas F Meyer; Tianmin Xu
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.